BioNTech SE - ADR vs General Dynamics Corporation — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while General Dynamics Corporation trades at $391.11 (market cap $107.13B). The key difference: General Dynamics Corporation is far larger — about 4.6× BioNTech SE - ADR's market cap, and General Dynamics Corporation pays a 1.61% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | GD | |
|---|---|---|
Market Cap | $23.31B | $107.13B |
Sector | Health | Industrials |
52-Week High | $119.34 | $395.97 |
52-Week Low | $83.89 | $312.53 |
Enterprise Value | $6.60B | $112.28B |
Dividend Yield | — | 1.61% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →